Amylyx drug helps slow ALS progression in mid-stage study
(Reuters) – Privately held drug developer Amylyx Pharmaceuticals Inc said on Tuesday its experimental therapy to treat amyotrophic lateral sclerosis (ALS) helped slow the progression of the fatal neurological disorder in a...
Read More